In the investigation of FLG2 immunoreactivity in skin biopsies from patients with AD and psoriasis vulgaris, two of the most common inflammatory skin diseases, we have observed decreased expression of FLG2 only in the lesional but not in uninvolved skin of psoriasis patients. Here, FLG2 is linked to psoriasis.